SYNTHESIS AND CRYSTAL STRUCTURE ANALYSIS OF 3 - (4 - METHOXYBENZYL) - 2, 3 – DIHYDRO - 4H – CHROMAN – 4 - ONE by Simon, Lalitha et al.
European Scientific Journal   August 2013  edition vol.9, No.24  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
366 
SYNTHESIS AND CRYSTAL STRUCTURE 
ANALYSIS OF 3 - (4 - METHOXYBENZYL) - 2,  
3 – DIHYDRO - 4H – CHROMAN – 4 - ONE 
 
 
 
Lalitha Simon 
Department of Chemistry, Manipal Institute of Technology,  
Manipal University, Manipal 
S.Shalini 
C. R. Girija 
Chemistry Research Centre, SSMRV Degree College, Jayanagar, Bangalore 
K.K. Srinivasan 
Department of Pharmaceutical Chemistry, Manipal  College  of 
Pharmaceutical Sciences, Manipal 
T.V.Venkatesha 
Department of Chemistry, Jnana Sahyadri,  
Kuvempu University, Shankargatta 
 
 
Abstract 
 3-(4-methoxybenzyl)-2,3-dihydro-4H-chroman-4-one(C17H16 O3) was 
synthesized  by refluxing  2'-Hydroxydihydrochalcone dissolved in ethanol 
with paraformaldehyde and 50% aqueous diethylamine. The compound is 
characterized by IR,1HNMR, MS and X-ray diffraction studies. The X-ray 
structure analysis indicates that the crystal suffers from the positional 
disorder over two positions, atomC1 and C9 with required site occupancies 
of 0.590 and 0.410 leading to a conformational difference between the major 
and minor components. After applying similarity restraints, the final 
reliability index is  0.0275  for 2209 unique reflections .The crystal packing 
is stabilized by  inter molecular C-H…O, C-H…π  and π …π interactions. 
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Intermolecular interactions 
Introduction 
Homoisoflavanones belong to a small homogeneous group of 
naturally occurring oxygen heterocycles. The first homoisoflavanones to be 
isolated were eucomin and eucomol. Since then a large number of these 
compounds have been isolated from several genera within the Hyacinthaceae 
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family including Eucomis, Merwilla, Ledebouria, Veltheimia and 
Drimiopsis. The homoisoflavanones consist of a sixteen carbon skeleton 
which includes a chromanone, chromone or chromane ring system with a 
benzyl or benzylidene group at position C3 Naturally occurring 
homoisoflavanones that posses a 3-benzyl substituted chroman ring system 
as a common framework have been isolated from a wide range of natural 
sources and exhibit a variety of biological activities. Homoisoflavanones are 
also widely used as antioxidant, antiviral, antimutagenic, antiproliferative 
and antifungal agents. A variety of compounds having a benzopyran ring 
such as levcromakalim generally exhibit potent antihypertensive activity.                                  
As a continuation of our efforts towards synthesizing and reporting 
the crystal structure of biologically active heterocyclic compounds, the title 
compound was prepared and its crystal structure is now reported. The 
synthesis of the compound was followed by subsequent spectroscopic 
analyses using IR, Mass and 1H NMR techniques to confirm the presence of 
the supposed ring systems. The structure of the derivative 3-(4-
methoxybenzyl)-2,3-dihydro-4H-chroman-4-one was verified by single 
crystal X-ray diffraction so that its supramolecular structure could be 
investigated in terms of possible intermolecular interactions. 
Experimental 
Synthesis 
Experimental Procedure for the Preparation of 3-(4-methoxybenzyl)-
2,3-dihydro-4H-chroman-4-one 
The strategy for the synthesis of 3-(4-methoxybenzyl)-2,3-dihydro-
4H-chroman-4-one involved the preparation of 2'-hydroxychalcone 
intermediate by Claisen-Schmidt condensation. 4-methoxybenzaldehyde 
(leq) was reacted with 2'-hydroxyacetophenone (leq) in 40-50% of 
MeOH/KOH. The mixture was poured into crushed ice acidified with dilute 
hydrochloric acid and stirred well. The reaction mixture was kept in the 
refrigerator for overnight to precipitate 2'-Hydroxychalcone. 
2'-hydroxychalcones, saturated ammonium formate solution 
[methanol:THF(1:1] and 10% Pd/C  were refluxed for 90 minutes. The 
reaction mixture was filtered. The product which remained in the filtrate was 
isolated in good yield by dispersing the residue in water, extracting it with 
ethyl acetate, and drying over anhydrous Na2SO4 to obtain 2'-
Hydroxydihydrochalcone. 
2'-Hydroxydihydrochalcone was dissolved in ethanol and refluxed 
with paraformaldehyde and 50% aqueous diethylamine for 9 hrs. Ethanol 
was distilled off and the residue was taken up in ethyl acetate.Ethyl acetate 
was distilled off and the oily residue was column chromatographed over 
silica using pet ether: ethyl acetate(7:3) as eluent to get the 3-(4-
methoxybenzyl)-2,3-dihydro-4H-chroman-4-one  in 60-70% yield. The title 
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compound is characterized by spectroscopic and X-ray diffraction studies. 
The scheme for the synthesis is given below 
 
Scheme 
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i)  40% w/v alcoholic KOH, rt, 12-36 h; ii) 10% Pd-C, HCOONH4, MeOH-THF (1:1), 
reflux, 90 min iii) 50% v/v aq. diethylamine, (HCHO)n, EtOH, reflux, 9 h. 
 
Spectroscopic details 
 
Single crystal X-ray Crystallography 
        Single crystals of the title compound were grown using methanol as 
solvent by slow evaporation technique under ambient temperature. The 
crystal structure analysis has been determined by the X-ray diffraction 
method. The compound is known to crystallize in the monoclinic space 
group P21/n  and the unit cell parameters are,  a = 8.449(5)Å, b = 6.575(5) Å, 
c = 24.699(5) Å, β= 97.265(5)° , V  = 1361.1(13) Å 3 , Z=4, Dx= 1.309 
Mg/m3. The X-ray diffraction data for the title compound  was collected on a 
Bruker Smart CCD Area Detector, using MoKα(λ = 0.71073Å) radiation. 
Intensity data were collected up to a maximum of 24° in the ω–φ scan mode. 
The data were reduced using SAINT . The structure was solved by direct 
methods using SIR92 and refined by difference Fourier synthesis using 
IR(c m-1) MASS(m/z) 1H-NMR,400 MHz, 
solvent DMSO 
1687 (C=O str) 
1602 (C=C str) 
2926 (C-H str) 
M+268(20%),237,147,
121 (100%) 
 
 4.3(dd,J=15.2, 4.4Hz,1H,2-H), 
 4.2(dd,J=9.2, 3.2Hz,1H,2-H), 
 2.6(m,2-H, 9’-H),  3.5(S,3H,4’- 
OCH3), 7.7(dd,J=7.6, 1.6Hz,1H) 
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SHELXL97. The positional and anisotropic displacement parameters of all 
non-hydrogen atoms were included in the full-matrix least-square 
refinement. A total of  11770  reflections were collected, resulting in 2209 
[R(int) = 0.0275] independent reflections of which the number of reflections 
satisfying I>2σ(I) criteria was 1676. The crystal suffers from the positional 
disorder over two positions, atomC1 and C9 with required site occupancies 
of 0.590 and 0.410 leading to a conformational difference between the major 
and minor components. After applying similarity restraints, the final 
reliability index is  0.0275  for 2209 unique reflections.The R factor for 
observed data finally converged to R1 = 0.0382, wR2 = 0.0914. Molecular 
diagrams were generated using ORTEP-3. The mean plane calculation was 
done using the program PARST. 
Table.1  Crystal data and structure refinement for the title compound 
 
      Empirical formula                       C17 H16 O3  
      Formula weight                           268.30  
      Temperature                                293(2) K  
      Wavelength                                 0.71073 Å 
      Crystal system                            Monoclinic 
      Space group                                P21/n  
      Unit cell dimensions                    a = 8.449(5) Å, b = 6.575(5) Å , c = 24.699(5)Å      
                                                           α = 90.000(5)° , β= 97.265(5)° , γ= 90.000(5)° 
      Volume                                        1361.1(13) Å 3  
      Z, Calculated density                    4,   1.309 Mg/m3  
      Absorption coefficient                  0.089 mm-1  
      F(000)                                           568  
      Crystal size                                   0.30 x 0.25 x 0.20 mm  
      Theta range for data collection     2.47 to 24.33°  
      Limiting indices                         -9<=h<=9, -7<=k<=7, -26<=l<=28  
      Reflections collected / unique    11770 / 2209 [R(int) = 0.0275]  
      Completeness to theta = 24.33     99.6 %  
      Absorption correction                   Semi-empirical from equivalents  
      Max. and min. transmission         0.9824 and 0.9038  
      Refinement method                      Full-matrix least-squares on F2  
      Data / restraints / parameters       2209 / 18 / 202  
      Goodness-of-fit on F2                   1.038  
      Final R indices [I>2σ (I)]             R1 = 0.0382, wR2 = 0.0914  
      R indices (all data)                        R1 = 0.0543, wR2 = 0.1007  
      Extinction coefficient                    0.0030(10) 
  
      Largest diff. peak and hole           0.184 and -0.157 e.A-3 
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Table2. Non-bonded interactions and possible hydrogen bonds (Å, ◦). 
           (D-donor; A-acceptor; H-hydrogen) 
D—H· · ·A             D—H          H· · ·A           D· · ·A       D—H· · ·A 
 
C9-H9A…O2(i)       0.98              2.56               3.2841           131 
C15-H15...Cg(ii)      0.93              2.94               3.8095           153 
Cg…Cg (iii)                                                       3.588 
 
Symmetry code: (i) 1-x,1-y,-z (ii) 1-X,-Y,-Z (iii) -X,1-Y,-Z 
 
Results and Discussion 
Crystal structure analysis 
  Summary of the crystallographic data and other structure refinement 
parameters of the compound are shown in Table.1. Table.2 shows the 
respective hydrogen bond interactions of the compound. The ORTEP view 
of the molecule with atomic labeling (thermal ellipsoids drawn at 50% 
probability) is shown in Figure 1. Figure.2  and Figure  3 shows the packing 
of molecules in the crystal structure.      
Conformational Features 
  In the compound, the fused pyranone ring is substituted with the 
benzyl ring at C9 chiral carbon atom and is positioned equatorially to the 
chromanone ring. The dihedral angle between the planes of the benzyl and 
chromanone rings is 83.92°.The 4-aryl substituent (methoxy group) adopts a 
anti periplanar configuration with respect to C14–O3 bond(Torsion angle  
C(13)- C(14)- O(3) - C(17) = -172.08°). The fused pyranone ring with a 
chiral C9 atom at the point of substitution of a benzyl ring (C10-C16) is 
significantly puckered and adopts a conformation which is best described as 
half-chair form. The ring puckering parameters for the pyranone ring are  
Q(2) = 0.3789 Å., Q(3)  = 0.3160 Å, φ= 81.0833° , θ = 50.17 ° and 
puckering amplitude QT= 0.4934 Å respectively. All other bond lengths and 
bond angles are in the normal range. 
 
Figure 1. Ortep view of the title compound, showing 50% probability ellipsoids and the 
atom numbering scheme 
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Packing Features 
  The crystal structure is primarily stabilized by some interesting 
features that comprise intermolecular C–H. . . O interactions. An 
intermolecular C–H. . . O interaction results in the formation of an inversion 
dimer motif of graph set R22(8) as shown in figure.2. 
 
Figure.2   An  intermolecular C–H. . . O interaction forming an inversion dimer motif of 
graph set R22(8) 
 
  The molecular packing is further stabilized by π- π stacking 
interactions between the benzyl rings as the C11-C16 (-X,1-Y,-Z) is disposed 
at a distance of 3.588(3) Å. In addition, π - ring interactions of the type C–H. 
. . Cg (Cg  being the centroid of the rings) are also observed in the crystal 
structure.  
 
Figure 3.   A unit cell packing of the title compound showing C-H…O, Cg… Cg and C- 
H… Cg   interactions with dotted lines.  
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Conclusion 
  The present work reports the synthesis and X-ray structure analysis of 
homoisoflavanone derivative. The formation of the chroman-4-one moiety 
was confirmed by analytical data. The X-ray structure analysis indicates that 
the crystal suffers from the positional disorder over two positions, atomC1 
and C9 with required site occupancies of 0.590 and 0.410 leading to a 
conformational difference between the major and minor components. The 
fused pyranone ring with a chiral C9 atom at the point of substitution of a 
benzyl ring (C10-C16) is significantly puckered and adopts a half-chair form 
conformation. The crystal structure is primarily stabilized by intermolecular 
C–H. . . O interactions. An intermolecular C–H. . . O interaction results in 
the formation of an inversion dimer motif of graph set R22(8). The molecular 
packing is further stabilized by π- π stacking interactions between the benzyl 
rings. In addition, π - ring interactions of the type C–H. . . Cg are also 
observed in the crystal structure. 
Supplementary Material 
The CIF file was deposited at the Cambridge Crystallographic Data 
Centre, The deposition number is CCDC-873083. These data can be obtained 
free of charge via www.ccdc.cam.ac.uk/data_request/cif , by e-mailing 
data_request@ccdc.cam.ac.uk, or by contacting The Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK 
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